PNPLA4 Antikörper (AA 1-103) (HRP)
Kurzübersicht für PNPLA4 Antikörper (AA 1-103) (HRP) (ABIN7153384)
Target
Alle PNPLA4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-103
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human G0/G1 switch protein 2 protein (1-103AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PNPLA4 (Patatin-Like phospholipase Domain Containing 4 (PNPLA4))
-
Andere Bezeichnung
- GS2
-
Hintergrund
-
Background: Promotes apoptosis by binding to BCL2, hence preventing the formation of protective BCL2-BAX heterodimers.
Aliases: G0/G1 switch regulatory protein 2 antibody, G0/G1switch 2 antibody, G0s2 antibody, G0S2_HUMAN antibody, OTTHUMP00000034644 antibody, Putative lymphocyte G0/G1 switch protein 2 antibody, RP1 28O10.2 antibody
-
UniProt
- P27469
Target
-